Keywords: provalis, turnover, up, end-2002, uk-based, drugmaker, reported
Provalis turnover up 92% at end-2002
Article | 13 January 2003
UK-based drugmaker Provalis has reported unaudited sales for thesix-month period ended December 31, 2002, of L7.1 million ($11.4 million), an increase of some 92% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
